Source: Virtual Congress 2021 – COVID - 19 treatments



Rating:

Share or cite this content

Citations should be made in the following way:
H. Petty (Manchester, United Kingdom), L. Baines (Manchester, United Kingdom), E. Danielsson-Waters (Manchester, United Kingdom), C. Child (Manchester, United Kingdom), C. Templeton (Manchester, United Kingdom), J. Bright (Manchester, United Kingdom), S. Paterson (Manchester, United Kingdom), S. Brij (Manchester, United Kingdom), T. Gorsuch (Manchester, United Kingdom). Clinical outcomes and use of 4C mortality scoring in COVID-19 patients treated with Remdesivir in a large UK centre. 3683

Member's Comments

No comment yet.

Related content which might interest you: Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data. Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021 Observation cohort study of outcome of patients referred to a UK regional weaning centre Source: Annual Congress 2012 - The latest insights in chronic care Year: 2012 Epidemiological profile and clinical outcomes of patients hospitalized for COVID-19 in a medium complexity Brazilian hospital Source: Virtual Congress 2021 – COVID19, acute respiratory failure and basic science Year: 2021 Ten-year projected outcomes associated with increased use of triple therapies in UK patients with COPD using the COPD Health Outcome Policy and INtervention (CHOPIN) model Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021 Therapeutic failure among incident users of ß-lactam antibiotics: a real-world, cohort study, in primary care in Italy Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020 Community acquired pneumonia in the emergency department: Comparison of clinical indication to in-hospital treatment and severity scales predicting mortality Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Clinical management of patients newly diagnosed with COPD through targeted case finding and routine care: a longitudinal analysis of the TargetCOPD trial Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 A survey of asthma severity, comorbidities and treatments in a paediatric primary care cohort in the UK Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 An RDW-based score predicts mid-term mortality in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation study Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Use of the European society objective score (ESOS.01) as an outcome evaluation tool for lung cancer surgery in a tertiary care hospital Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases Year: 2009 Comparison of clinical features and outcome in COPD patients with and without heart failure, admitted at tertiary care hospital. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Deaths in risk classes I-III: a measure of quality of care in patients hospitalised with CAP? Source: Eur Respir J 2004; 23: 103-105 Year: 2004 Could a 2-year mortality prediction model have prevented deaths from respiratory failure: a single UK centre experience Source: Virtual Congress 2021 – Adult cystic fibrosis Year: 2021 Corelation of MRC gradings within a large single practice primary care COPD cohort in the UK Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Outcome of patients referred to a UK regional weaning centre Source: Annual Congress 2010 - Mechanical ventilation and weaning Year: 2010 Outcome of patients referred to a UK regional weaning centre Source: Annual Congress 2008 - Diagnosis and outcome in critically ill patients Year: 2008 An evaluation of ‘care bundles’ as a means of improving hospital care for patients with COPD: results of a multi-centre study in the UK Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 Survival analysis of PAH patients based on a multidimensional risk approach at baseline in Uruguay: 10 years of experience of a PH referral centre. Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Progress of quality indicator rates regarding treatment of patients hospitalized in Germany due to community acquired pneumonia (CAP) Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Prevalence of comorbidities in established and newly treated patients with COPD according to GOLD 2017 in a UK primary care population Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018